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INTRODUCTION. We use multilevel modeling (MLM) to parse out the effects of time-varying 
smoking abstinence and baseline depression (history and severity) on depression severity over 
one year.  
METHODS. Participants were 1,000 smokers recruited worldwide for an online randomized 
controlled tobacco cessation trial. We examined whether changes in depression severity over 
time were associated with self-reported 7-day point prevalence smoking status assessed at 1-,3-
,6-, and 12-month follow-up using baseline major depressive episode (MDE) history and 
baseline depression severity as time-invariant covariates. We present depression severity means 
and smoking abstinence at each follow-up.  
RESULTS. Regardless of concurrent abstinence status, baseline MDE history was significantly 
related to depression severity over time: those reporting a past MDE had worse depressive 
symptoms over time compared with those reporting no MDE history. Baseline depression 
severity interacted significantly with time-varying abstinence status: for every 1-unit increase in 
baseline scores on the Center for Epidemiological Studies Depression Scale (CES-D), 
individuals who were smoking at follow-up reported CES-D scores that were 0.17 points higher 
than those who were abstinent. In this context, nicotine dependence, gender, age, or marital 
status did not affect depression severity.  
CONCLUSIONS. In the context of cessation, having an MDE history plays a significant role in 
the trajectory of depression severity over the course of one year, regardless of abstinence status. 
Abstinence is related to lower depressive symptoms at each follow-up, and this effect was 
stronger at higher levels of baseline depression severity.  
 
 
Implications. This study indicates that depressive symptoms are not exacerbated among 
individuals who are quitting smoking at 1-, 3-, 6- and 12-month follow-ups. Depression severity 
is worse with a baseline history of major depressive episode. Further, those with high baseline 
depression severity who continue smoking have worse depressive symptoms throughout a one-
year period compared to their abstinent counterparts. 
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INTRODUCTION  
Globally, tobacco use is the main cause of preventable death and disproportionately 
affects individuals with mental disorders.
1
 Guidelines recommend the integration of tobacco 
cessation into routine mental health care settings.
2
 Prior to this integration however, it is critical 
to understand the effect of abstinence on depression symptoms, while also parsing out the roles 
of baseline depression history and baseline depression severity. If abstinence exacerbates 
depression, clinicians need to be aware of and prepared to address this in a clinical context. If 
abstinence improves depression, this might increase the engagement of both clinicians and 
patients in tobacco cessation in these settings. If either of these relationships are affected by 
baseline depression history and baseline depression severity, clinicians should tailor cessation 
integration accordingly.  
Many studies have explored the relationship between abstinence and depressive 
symptoms categorically—whether or not tobacco cessation resulted in the later development of a 
major depressive episode (MDE)—while also accounting for the special risk among those with a 
prior MDE history.
 
Generally, those who successfully quit smoking but also had an MDE history 
were at risk for developing another MDE after cessation compared to those who did not have an 
MDE history.
3,4,5,6,7
 For example, at 3-month follow-up (FU) in a cessation study, the incidence 
of a new MDE was 2%, 17%, and 30% among abstinent individuals with no history of 
depression, single major depression, or recurrent major depression, respectively.
4
 At 3- and 6-
month FU, heavy smokers with a history of depression who abstained from smoking in the final 
two weeks of treatment were more likely to develop a recurrent episode of depression compared 
with those who continued to smoke.
 6
 At 12-month FU, the incidence of MDE was 14.1% for the 
entire sample after smoking cessation treatment and the development of a later MDE was 
significantly different based on baseline history of MDE—23.7% 12-month MDE incidence 
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among those who had a history of depression compared with 9.7% among those with no history 
of depression.
 7
 At 1-, 3-,6-, and 12-month FU, in a previous analysis that included a sub-sample 
of all recruited participants from our study who did not meet criteria for a current MDE at 
baseline, a past MDE—but not abstinence—was associated with development of a later MDE.8 
In another study, smokers with an MDE history who returned to smoking had a higher risk of 
later developing an MDE and abstinence did not increase risk of MDE incidence but rather was 
associated with non-significant lower risk.
9
 
One potential limitation to these traditional approaches is that they do not capture 
variation of depressive symptoms at different intervals, which may be more important and more 
informative clinically than a categorical diagnosis. Also, the majority of prior studies did not 
capture the time-varying dimension of abstinence itself. Quitting smoking, after all, typically 
includes periods of smoking and abstinence over time and is rarely a linear process or one-time 
event.
10
 These limitations have made it difficult to disentangle whether MDE history, abstinence, 
or both, contribute to later depressive symptoms.  
There is now a growing body of studies which have begun to capture the time-varying 
association between tobacco cessation and depression severity using advanced statistical models, 
such as multilevel modeling (MLM). This approach can help with understanding the nuanced 
relationship between MDE history, time-varying depressive symptoms and time-varying 
abstinence using longitudinal data. One of the studies
9
 mentioned earlier explored the 
relationship between depression and abstinence in the course of smoking cessation that 
incorporated cognitive-behavioral treatment for depression and found that abstinence was related 
to reduced depression severity a year later. In another longitudinal study, composed of heavy 
drinking smokers, abstinence was associated with a reduction in depressive symptom severity, an 
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MDE history was not related to abstinence patterns, and an MDE history did appear related to 
later depression symptom severity.
 11
 In a longitudinal study of perinatal women, abstinence was 
associated with a reduction in depression symptom severity; however, this study did not look at 
those seeking smoking cessation treatment.
12
 A recent study exploring a combined treatment for 
smoking cessation in heavy drinkers found that abstinence from smoking was associated with 
significantly lower depressive severity over a 26-week period.
13
 
In the current study, using data from a previous Internet-based worldwide smoking 
cessation trial, we use MLM to examine the relationship between time-varying abstinence and 
depression symptoms measured at 1-,3-,6-, and 12-month follow-up, accounting for a history of 
MDE assessed at baseline and baseline depression severity. Based on a systematic review of 
previous studies on the relationship between smoking and mental health,
14 
we also control for 
differences in nicotine dependence, gender, ethnicity, and educational status. Therefore, our 
questions are as follows: 1) in the context of a cessation trial, what are the effects of time-varying 
smoking abstinence and time-invariant baseline depression (history and severity) on depression 
severity over time? 2) In this context, do nicotine dependence, gender, ethnicity, and education 
moderate changes in depression severity?  
METHODS 
Data were collected as part of an international, web-based randomized control trial for 
tobacco cessation in which 500 Spanish-speaking and 500 English-speaking adult Internet users 
(smoking at least 5 cigarettes/day and intending to quit in the next month) were recruited online 
from 68 countries. Details of this study are available elsewhere.
 15,16
.
 
Briefly though, participants 
were recruited using a Google AdWords campaigns targeted at English- and Spanish-speaking 
smokers from any country. Smokers came to the site via search engines after entering relevant 
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key words, links from other Web sites, media stories, and word of mouth.  The website was 
described as a “Free online University of California Stop Smoking Study” which entailed an 8-
week program for tobacco smokers who were ready to quit. Participants were informed that they 
would be contacted at 1-, 3-, 6-, and 12-month follow-up (FU) after their study entry to answer a 
brief questionnaire.  
Study Procedures 
Interested individuals logged onto a website and responded to an 11-item eligibility 
questionnaire, which included being 18 years of age, smoking five or more cigarettes daily, using 
e-mail at least once weekly, and planning to quit within the next 3 months. Those eligible were 
presented with an online institutional review board-approved consent form. Consenting 
participants provided baseline demographics, smoking characteristics, lifetime and current MDE 
symptoms, and depressive symptom severity using established measures. Those not eligible or 
not consenting could access a smoking cessation guide online.  
To screen out those merely browsing and unlikely to return, potential participants who 
completed the baseline questionnaire were asked to log daily cigarette use on an online cigarette 
counter on three separate days within the following week. E-mail reminders were sent daily until 
the third entry or the seventh day. After their third entry, participants were asked to set their 
initial quit date within the next 30 days. Follow-ups were keyed to the initial quit date, although 
users could change it later. Those who logged cigarettes smoked on 3 days within a week and set 
a quit date were randomized to one of four conditions and taken to an individualized home page. 
Participants could access their designated interventions throughout the 12-month follow-up 
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period. Self-reported 7-day abstinence was defined as a ‘‘no’’ response to the question, ”Have 
you smoked 1 or more cigarettes in the last 7 days?” 
Each condition added new elements: Condition 1 was the static National Cancer Institute 
evidence-based Guide to Stop Smoking
17
 which covers reasons to quit, cessation strategies, 
relapse prevention and management, information about pharmacological aids, and how to help a 
smoker quit. They were also provided an online journal to record experiences while quitting. 
Condition 2 consisted of Condition 1 materials plus e-mail reminders to return to the site. 
Condition 3 consisted of Condition 2 materials plus cognitive-behavioral mood management 
strategies, which were an extended version of an intervention tested previously.
18
  Condition 4 
consisted of Condition 3 materials plus a “virtual group” (an asynchronous bulletin board for 
mutual support and suggestions).  
Participants 
Baseline measures were collected from participants about standard smoking 
characteristics, sociodemographic characteristics (e.g., age, gender, marital and status, ethnicity, 
race, and educational attainment), and depressive symptoms (e.g., MDE history and symptom 
severity). Participants reported smoking status and completed the depressive symptoms measures 
at baseline and at follow-ups at 1-, 3-, 6-, and 12- months. Demographic, smoking, and clinical 
characteristics of our sample are shown in Table 1 and additional details can be found in a prior 
publication.
15
 Each of the four conditions had roughly a quarter of the total sample, with 24.7% 
individuals in Condition 1 and 25.1% in Conditions 2 to 4. Slightly more than half were men 
(55.5%). At baseline, 69.7% of individuals reported no MDE history, 17.3% a past MDE, and 
12.9% a current MDE.  
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Measurements 
Depression severity. Center for Epidemiologic Studies-Depression Scale (CES-D).
 19
 Depressive 
symptoms were determined by the CES-D, a continuous measure of self-reported depressive 
symptoms in the general population.
20
 Scores range from 0-60 with higher scores indicating 
more depression and scores of 16 or higher representing clinically significant depression. 
Previous studies have demonstrated the validity and reliability of this measure administered over 
the Internet.
 21
 The CES-D was administered at baseline, and at 1-, 3-, 6-, and 12-month FU 
periods and, as noted in Table 2, CES-D completion rates were 72.5%, 65.1%, 55.8%, and 68.3%, 
respectively. 
MDE history. The MDE Screener
22
 is an 18-item measure designed to screen for the presence 
and absence of current and past MDEs.  It assesses the presence of nine symptoms of depression 
according to the Diagnostic and Statistical Manual, Fourth Edition
23
 over a period of 2 weeks or 
more and assesses whether significant functional impairment is met within the same time span. 
All participants reported whether they had ever experienced any of the nine MDE symptoms 
during a 2-week period (lifetime MDE) and then whether any of the symptoms ever experienced 
for 2 weeks were currently present (current MDE). Those screening positive for a lifetime MDE 
but not for a current MDE were designated as having a past MDE. This resulted in three non-
overlapping categories: past MDE, current MDE, and no MDE history. The screener has good 
agreement with established measures,
24,25
 and with clinician-administered diagnostic 
interviews.
26
 The screener was completed at baseline and all FU periods; for our purposes, we 
were interested only in this assessment at baseline. As noted above, this categorical variable was 
assumed to not be as good a dependent variable as a continuous measure (CES-D) to capture 
fluctuations in depression severity over time. 
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Nicotine Dependence and Smoking History. The Fagerstrom Test for Nicotine Dependence 
(FTND)
27
 is a standardized ordinal measure of nicotine dependence related to cigarette smoking 
and assesses quantity of cigarette consumption, compulsion to use, and dependence. At baseline, 
smokers were asked to complete the FTND, as well as indicate their smoking history and length 
of time of smoking. These data are presented in Table 1.  
Smoking Status. Abstinence was assessed as self-reported 7-day point prevalence, which has 
been established by expert consensus as an appropriate outcome measure for smoking 
cessation
28,29 
and generally corresponds well with bioverification measures.
30
 The SRNT 
Subcommittee on Biochemical Verification also found that biochemical verification is not 
required and may not be desirable in large-scale studies where the optimal data collection 
methods are through the Internet.
31
 
Data Analysis Plan 
We applied MLM estimated using SAS PROC GLIMMIX to explore whether abstinence 
at any follow-up period was associated with concurrent CES-D scores. Our model accounted for 
those who at baseline identified as having a past, current, or no history of an MDE and 
demographic variables such as gender, age, ethnicity, FTND, and education as covariates. Table 
2 provides CES-D means and smoking abstinence rates at 1-month, 3-month, 6-month, and 12-
month FU. We examined the overall pattern of and individual differences in CES-D scores over 
the follow-up periods. Restricted maximum likelihood (REML) was used for model estimation; -
2 log-likelihood, Akaike Information Criterion (AIC) and Bayesian Information Criterion (BIC) 
were reported as model fit indices; and degrees of freedom were estimated using the 
Satterthwaite method. We selected an alpha level of .05 and assumed data were missing at 
random (data were missing for various reasons despite our best efforts to gather complete data 
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using extensive follow-up procedures);
32
 under this assumption, MLM uses maximum likelihood 
estimation method to handle missing data, yielding consistent and asymptotically efficient 
estimations.
 33
 A polynomial model was fit to estimate the effect of the intervention on the CES-
D scores across the FU periods. Time was centered at the first FU period and the intercept 
represented the CES-D score at 1-month. The first of the five observations was at baseline (or 
month 0); as we examined change, we were interested in the four subsequent FU periods and 
change was expected as a linear (rather than quadratic or higher) form of time. To select 
appropriate polynomial trends, we visually inspected spaghetti diagrams,
34
 which revealed 
possible variation in change rate across smokers. Thus, we fit two unconditional models (i.e., 
with and without a random slope) with only time as the fixed effect. The model with a random 
slope fit better than the model without a random slope,   ( )            . For this reason, 
both the random intercept and random slope were included in the random portion of the model. 
We applied a top-down approach to model building (see Figure 1 for full details). Cohen’s f2 35 
and the significance of the fixed effects were criteria of model selection. The resultant final 
model is shown in Table 3. 
RESULTS 
Intra-class correlations (ICCs) and Baseline Longitudinal Model 
MLM parses out variance due to between-person (i.e., cross-sectional) versus within-person (i.e., 
changes in an individual over time) differences. An empty model (i.e., random intercept-only) 
was fit to determine the intra-class-correlation (ICC) of the outcome variable. Between-person 
variance was 81.7 and within-person variance was 58.5. The ICC demonstrated that 58.2% of the 
variance is due to between-person dependency and 41.8% to within-person dependency, 
indicating that depression severity varies at the within-person level and thus, the suitability of 
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MLM for these data. As shown in Table 3, the random intercept was significant (p<.01), 
indicating significant variation in intercept across individuals. The overall intercept indicated that 
the initial CES-D score is 13.73 for those who at baseline have no MDE history and are abstinent 
at 1-month FU. Further, 95% of the individual intercepts fell within the interval of 13.73±11.47.  
Condition and Time on Depression Severity 
Prior to our analyses, we tested the effect of condition on depression severity. As the 
primary focus of the intervention was on tobacco cessation, we sought to clarify that groups did 
not vary significantly in their depression severity scores based on condition. The omnibus test for 
condition was not significant F(3,258)=1, p=.40. 
Baseline Depression History and Concurrent Abstinence Status on Depression Severity  
To address our first hypothesis, the interaction between the covariate baseline MDE 
history and abstinence status on depression severity at each FU period was not significant in 
Model 2, p=.78. That is, the effect of concurrent abstinence status on depression severity at any 
FU period was not significantly different among those who at baseline reported no MDE history, 
a past MDE, and a current MDE. See Table 2 for abstinence status and depression severity scores 
at each FU period by baseline MDE history. Note that depression scores were lower for those 
who were abstinent at ach assessment period for all three depression history groups. The main 
effect of baseline MDE history, however, was significant in the final model: compared with 
those who at baseline indicated no MDE history, those who at baseline reported a past MDE had 
a CES-D score that was 2.61 points higher than those reporting no MDE history at baseline, 
p=.01. Compared to those who at baseline indicated no MDE history, those who at baseline 
reported a current MDE had a higher depression severity score at each FU point, though this was 
not significant (p=.23).  
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Baseline Depression Severity and Concurrent Abstinence Status on Depression Severity 
The interaction between baseline CES-D scores and abstinence status was significant, 
p<.0005. For every 1-unit increase in baseline CES-D scores, individuals who were smoking 
reported 0.17 higher concurrent CES-D scores at FU periods compared to those who were 
abstinent, as shown in Figure 2. That is, smokers with higher CES-D scores at baseline had 
higher CES-D scores at each FU if they were smoking at that FU than if they were abstaining. 
Those who were smoking scored 0.76 points higher on concurrent CES-D than those who were 
abstinent at 1-month FU, but this was not significant, p= .46. Over time, however, this increased 
by 0.28 points per month, p=.05, revealing that the interaction between abstinence status and FU 
period was significant. For example, at 12-month FU, a smoker scored 3.36 (.28*12) points 
higher on their concurrent CES-D than those who were abstinent. To ensure baseline MDE 
history or baseline CES-D scores did not contribute to this, we explored whether this effect was 
explained by 3-way interactions (i.e., baseline MDE history x time x abstinence or baseline CES-
D x time x abstinence status); neither of these was significant.  
Demographic and Smoking History Factors 
Within this context and as seen in Table 3, FTND was not significant in the final model. 
Gender and education were not significant predictors of depression severity (p=.45 and p=.24, 
respectively). Ethnicity was significant, however: individuals who identified as Hispanic or 
Latino/a had a 1.50 higher CES-D score over time compared with those who identified as not 
Hispanic or Latina/o, p=.04. 
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DISCUSSION 
This study contributes to our understanding of the effects of time-varying abstinence and 
baseline current or past depression and severity of depressive symptoms on later depression 
severity in four main ways.  First, the effect of time-varying abstinence on concurrent depression 
severity did not differ between those with and without a baseline MDE history. Second, 
compared with those who indicated no MDE history at baseline, those who reported a past MDE 
at baseline had higher depression severity scores at each FU. An MDE history appears related to 
worsened depression severity over time. These results are consistent with another report which 
found that a past MDE, and not abstinence, was associated with development of a later MDE.
8
 
Our results indicate that this holds true for continuous measures of depression symptom severity.  
Third, among those with higher depressive symptoms at the outset, smoking rather than 
abstinence appears related to exacerbated depression symptoms. This is consistent with a study 
from smoking heavy drinkers who used a similar analytical approach: those reporting higher 
baseline depression scores had higher depressive symptoms at follow-up if they were 
concurrently smoking compared to their abstinent counterparts.
 11
 Another study among heavy 
drinkers similarly found smoking abstinence to be associated with reduced depressive 
symptoms.
13
  
Finally, in our study, gender, education and smoking history were not related to 
exacerbations in depression symptom severity. The negative findings of gender and education 
are consistent with a recent systematic review
14
 which found inconsistent findings on these 
factors. Ethnicity however, was related to depressive symptom severity: those identifying as 
Latina/o or Hispanic reported worse depressive symptoms over time. Past research has noted 
differences in the unique mental health needs of this population in the United States versus 
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elsewhere.
36,37
 Our work adds to this larger conversation in the context of tobacco cessation and 
mental health. 
Our results are also consistent with a systematic review
38
 on broader mental health 
systems which concluded that across 26 studies, abstinence is associated with improved mental 
health symptoms compared to those who continue to smoke. Furthermore,
 
using MLM, we were 
able to capture the within-person variability in depression severity and smoking cessation that go 
beyond traditional methods of between-person change. This method has several advantages, 
which have been described by others
11
 and our work adds to a growing body of literature using 
these methods to capture complexity in the tobacco cessation process. Our study also adds 
encouraging results that among those who endorse high baseline depression severity, 
incorporating tobacco cessation can improve depression symptoms over time.
 
This study also adds to a slowly growing body of literature highlighting the importance of 
prioritizing tobacco cessation for those with mental health problems, ideally integrating such 
services into routine mental health care through adjunctive in-person or technological-based 
services. Major professional and public health organizations like the World Health Organization 
have published recommendations exhorting mental health providers to address tobacco cessation 
with every patient.
39
 Despite this, many mental health clinicians continue to believe this may be 
harmful to patients, a low priority, or not achievable by patients with severe mental disorders.
40
 
This also goes against our own findings: depression improved with abstinence across all MDE 
history groups across FU periods (Table 2). Utilizing technology may help with access to these 
interventions and may provide an unprecedented opportunity to disseminate resources.
 41,42
 
Special attention to tobacco cessation for clinical populations with high rates of smoking (e.g., 
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individuals with severe mental illness) will also likely prove valuable. Future studies should 
explore the integration of technology-based tobacco cessation into routine mental health care. 
Limitations. It is worth noting that in our sample, baseline CES-D scores for all three depression 
history groups were higher than in the general population, which have been reported to have a 
mean of 8.7 (SD = 8.4).
43,44
 This suggests that either smokers or at least smokers seeking 
smoking cessation tools online may have higher depression levels than non-smokers, which has 
been shown in prior studies.
45
 We did not explore the specificity of time-varying abstinence 
trajectories (e.g., smoking to abstinent, abstinent to smoking, continuous smoking, continuous 
abstinence) or latent class trajectories on depressive symptoms, which have been elegantly 
modeled by others.
9,11
 It is possible that specific characteristics of abstinence trajectories (e.g., 
long stretches of smoking followed by abstinence or long stretches of abstinence followed by 
smoking) may have had an impact on depression severity symptoms that were not captured by 
our analyses. Although medication and other methods used to quit were assessed in our sample,
15
 
this was not a focus of the current analysis. It is possible that our results may have been affected 
by non-study methods used to quit. We also did not have biochemical verification of abstinence 
status and relied on self-report for smoking status.  This method has been recommended for 
large-scale studies without face-to-face contact.
31
 As noted above, our finding that identifying as 
Hispanic/Latino/a in a worldwide sample was associated with high depressive symptoms over 
time regardless of smoking status appears different from prior studies based solely in the United 
States.
36
 Future studies should further explore the replicability of this finding.  
Our results highlight the differences in measuring depression diagnosis categorically 
(presence/absence of MDE history) versus as a continuous symptom variable (CES-D) that 
captures severity. It is possible such granularity is helpful for parsing out how depression and 
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abstinence status interact in a more fine-grained way; however, it is also possible that these 
fluctuations in CES-D scores may represent statistically but not clinically significant change.
 46
 
Continuous measures may help us understand in finer detail the reductions and exacerbation of 
symptoms; whereas the diagnostic variables help us understand the clinical significance of these 
impacts. Our study was unable to clearly delineate this. Future studies should explore the clinical 
significance of mood changes over time. 
Although our data were comprehensive in depression severity, we did not have 
information on whether participants were receiving concurrent psychological or pharmacological 
depression treatment at each time period. Nevertheless, our results are similar to another 
worldwide online randomized controlled trial, which explored as an outcome variable the 
prevalence of depression prescriptions and found that compared with current smokers, those who 
were abstinent reported a lower prevalence of depression prescriptions.
47
 
This study addresses the concern that abstinence from smoking may negatively affect 
mood. Our data support earlier studies showing that successful abstinence at a specific timepoint 
is associated with lower depressive symptoms at the same timepoint. These findings should 
encourage the integration of tobacco cessation resources into routine mental health care settings 
and should be an encouragement to clinicians and smokers alike. Quitting smoking is associated 
with improved mood. 
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Table 1. Baseline Characteristics of 1,000 Cigarette Smokers from 68 Countries, by History of 
Major Depressive Episode (MDE), Randomized to Tomando Control Study (2005-2007) 
Variable Total N N (%) No MDE
a 
N (%) 
Past MDE
a
 
N (%) 
Current 
MDE
a
 
N (%) 
 1000  697 (69.7%) 173 (17.3%) 129 (12.9%) 
Gender      
% Women 
% Men 
996 
443 (44.6) 
553 (55.4) 
295 (42.6) 
402 (57.4) 
94 (54.7) 
79 (45.3) 
54 (41.9) 
75 (58.1) 
Language      
% Spanish speakers 
% English speakers  
998 
499 (50.0) 
499 (50.0) 
343 (49.3) 
354 (50.7) 
73 (42.2) 
100 (57.8) 
83 (64.3) 
46 (35.7) 
Marital Status      
% Partnered
b 
% Non-partnered 
997 
539 (54.1) 
458 (45.9) 
403 (57.9) 
294 (42.1) 
84 (48.8) 
89 (51.2) 
52 (40.3) 
77 (59.7) 
Ethnicity      
% Hispanic or 
Latino/a 
% Not 
Hispanic/Latino/a 
973 
515 (52.9) 
458 (47.1) 
356 (52.8) 
341 (47.2) 
74 (43.3) 
99 (56.7) 
85 (66.4) 
44 (33.6) 
Variable Total N Overall  
Mean 
(SD)
 d
 
No MDE
a 
Mean (SD)
 d 
Past MDE
a 
Mean (SD)
 d
 
Current 
MDE
a 
Mean (SD)
 d
 
Age (years) 999 37.9 (11.3) 38.4 (22.7) 35.8 (10.7) 35.3 (11.1) 
Education (years) 993 13.1 (2.1) 13.1 (2.2) 13.0 (1.86) 13.1 (1.82) 
Smoking history      
Age (years), first 999 15.6 (3.30) 15.7 (3.1) 15.2 (2.8) 15.8 (4.7) 
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cigarette 
Age (years), regular 
smoker 
993 18.3 (4.0) 18.4 (3.9) 17.3 (3.7) 18.7 (4.8) 
Years smoked 1000 21.4 (11.7) 21.9 (11.9) 20.6 (10.9) 19.4 (11.7) 
Cigarettes per day 1000 19.8 (10.1) 19.5 (10.4) 20.4 (9.5) 19.9 (9.4) 
FTND
e
 997 5.2 (2.5) 5.0 (2.5) 5.6 (2.4) 5.7 (2.5) 
Depression      
CES-D
f
 (baseline) 996 16.0 (11.6) 12.2 (8.4) 17.6 (9.6) 34.2 (10.9) 
a
MDE=Major Depressive Episode; 
b
Partnered=Married or Living with Partner; 
c
Mestizo=Person of mixed Spanish 
and Indigenous ancestry; 
d
SD=standard deviation, 
e
FTND=Fagerstrom Test for Nicotine Dependence; 
f
CES-D, 
Center for Epidemiological Studies-Depression Scale 
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Table 2. Depression severity scores by self-reported 7-day smoking abstinence and follow-up 
period, Tomando Control Study, 2005-2007 
 
  No MDE
a
 History Past MDE Current MDE 
  Smoking Abstinent Smoking Abstinent Smoking Abstinent 
 Total 
N 
% % % % % % 
Baseline 1,000 100 0 100 0 100 0 
1-month 725 
(72.5) 
76.1 23.9 79.2 20.8 75.0 25.0 
3-months 651 
(65.1) 
75.1 24.9 72.8 27.2 72.3 27.7 
6-months 558 
(55.8) 
73.7 26.3 74.8 25.3 72.7 27.3 
12-
months 
683 
(68.3) 
69.2 30.8 70.3 29.8 71.9 28.1 
 CES-
D 
Mean 
(SD
b
) 
Mean 
(SD) 
Mean 
(SD) 
Mean 
(SD) 
Mean 
(SD) 
Mean 
(SD) 
Baseline 
1000 
12.20  
(8.45) 
-- 
17.60 
(9.57) 
-- 
34.21 
(10.88) 
-- 
1-month 725 
(72.5) 
13.17 
(10.48) 
11.88 
(9.87) 
20.04 
(12.28) 
14.54 
(11.48) 
26.12 
(13.63) 
19.57 
(12.43) 
3-months 651 
(65.1) 
12.04  
(9.81) 
10.50 
(10.35) 
17.63 
(12.71) 
13.70 
(8.90) 
26.76 
(12.01) 
18.26 
(12.98) 
6-months 558 
(55.8) 
11.45  
(9.92) 
8.97  
(7.12) 
18.89 
(12.97) 
12.29 
(12.09) 
24.98 
(14.25) 
18.80 
(10.50) 
12-
months 
683 
(68.3) 
11.45 
(10.92) 
9.31  
(9.91) 
18.51 
(13.92) 
10.74 
(11.01) 
25.00 
(14.73) 
15.20 
(13.21) 
a
MDE=Major Depressive Episode; CES-D=Center for Epidemiological Studies—Depression 
Scale; 
b
SD=standard deviation. 
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Table 3. Model Results of Predicting Depression Symptoms on the CES-D 
   Estimate SE
a
 p 
Fixed Effects       
Intercept (   ) 13.73 1.25 - 
Condition 4
b
 (   , reference = Guide + e-mail + mood 
management + virtual group) 
   
1=Guide  (    ) -.1.04 1.01 .30 
2=Guide + e-mail (    ) -1.56 1.01 .13 
3=Guide + e-mail + mood management (    ) -1.38 1.01 .17 
Gender (    reference=male) -.54 0.72 .45 
MDE
c
 history (   , reference=No MDE History)    
Past MDE  (    ) 2.61 0.98 .01 
Current MDE (    ) 1.65 1.37 .23 
Education
d
 (   ) -.20 .17 .24 
Ethnicity (    reference=Not Hispanic or Latina/o) 1.50 0.73 .04 
Age (   ) 0.04 0.03 .19 
Baseline CES-D
e
 (   ) 0.37 0.06 <.01 
FTND
f 
(   ) 0.09 0.15 .55 
Abstinence status (    reference=abstinent) 0.76 1.02 .46 
Baseline CES-D x Abstinence status (   ) 0.17 0.06 .003 
Follow-up month (   ) -0.29 0.12 .01 
Follow-up month x Abstinence status (   ) 0.28 0.14 .05 
Random Effect    
Random Intercept (   ) 34.23 4.72 <.01 
Random Slope (   ) 0.22 .08 <.01 
Residual (  ) 54.07 3.33  
Model Fit    
-2 Log Likelihood 8769.11   
AIC
g
 8775.11   
BIC
h
 8788.46     
    
Note: 
a
SE=standard error; 
b
See text for more details about each of the four conditions; 
c
MDE=Major Depressive Episode; 
d
Education in years;
 e
CES-D=Center for Epidemiological 
Studies—Depression Scale; fFTND=Fagerstrom Test for Nicotine Dependence; gAIC=Akaike 
Information Criterion; 
h
BIC=Bayesian Information Criterion 
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Figure 1. Final Model Equations 
Level 1: 
              (            )     (       )     (            )  (       )      
Level 2:  
           (          )     (       )     (    )     (          )  
       (          )      (    )     (              )     (     )         
(1) 
           (              ) 
        +       
              (   
 )    (
   
   
)  ( (
 
 
) (
    
    
) )  
Note: In the Level 1 model, Center for Epidemiological Studies-Depression (CES-D) scores are a 
function of within-person abstinence status (smoking vs. abstinent), within-person follow-up 
month, and their interaction with the effect of    . In the Level 2 model, the individual intercept 
is a function of the number of between-person predictors including condition (1, 2, 3, 4), gender 
(female vs. male), Major Depressive Episode (MDE) history (none, past, current), education in 
years, ethnicity (Hispanic/Latino vs. Not Hispanic/Latino), age, baseline CES-D, and Fagerstrom 
Test for Nicotine Dependence. We also include the interaction between abstinence and baseline 
CES-D. Bolded variables are vectors. Please see Supplementary Materials for more details for 
the model and the model building process. 
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Figure 2: Interaction between Baseline CES-D Score and Abstinence Status on 
Depression Severity  
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